Find Academic Supervisors

John HuntView profile

Professor

• Tissue Engineering
• Biomaterials
• Regenerative Medicine
• +7 more

Professor John Hunt is a distinguished academic and researcher at Nottingham Trent University (NTU), where he serves as Head of the NTU Strategic Research Theme within the School of Science & Technology. With a career spanning over three decades, Professor Hunt has established himself as a leading expert in biomaterials, tissue engineering, and regenerative medicine. His research focuses on developing breakthrough therapies and devices to repair, replace, augment, and regenerate diseased or damaged tissues using material interventions, with particular emphasis on cellular responses to implanted materials. Professor Hunt earned his Ph.D. in 1992 and D.Sc. in 2006, both from the University of Liverpool. His educational foundation in clinical engineering has enabled his interdisciplinary approach that bridges engineering, materials science, and medicine. He has received research funding from major organizations including the European Commission, BBSRC, MRC, and EPSRC, as well as industry partners. Professor Hunt's research interests center on understanding the fundamental science behind interventional medical therapies requiring material use. His work takes a first-principles approach to directing cellular and molecular mechanisms related to clinical outcomes, biocompatibility, inflammation, and stem cell biology. His specific applications span musculoskeletal tissues (cartilage and bone), visceral and vascular tissues. His publication record demonstrates leadership in developing tissue engineering processes and biomaterials for clinical applications. His recent research (2021-2025) shows expansion into novel areas including perovskite-graphene biosensors for cytokine detection, noninvasive breast cancer detection technologies, nanoarchitectonics of bactericidal coatings, and textile-based protein sensors for wound monitoring. These works reflect his ability to bridge fundamental materials science with practical clinical applications. Chair of the Committee of Analytical Biosciences Group, The Royal Society of Chemistry (2004) Steering committee member and elected treasurer, International College of Fellows of Biomaterials Science and Engineering (2016) Athena Swan Review Panel Member (2014) Wellcome Trust Innovations Advisory Group (2012) International Board Member for Journal Biomaterials (2002) Professor Hunt has organized seven national and international conferences, including the European Society for Biomaterials meeting in 2014. He holds multiple patents related to osteoinductive materials, stem cell culture methods, and cell growth technologies, demonstrating his commitment to translating research into practical applications. His work continues to advance regenerative medicine through innovative biomaterials development and tissue engineering approaches.

• Neuroimmunology
• Cognitive Neuroscience
• Behavioral Neuroscience
• +3 more

Aminata Coulibaly is an Assistant Professor at West Virginia University School of Medicine with dual appointments in the Department of Neuroscience and the Rockefeller Neuroscience Institute. Her research program investigates the critical intersection between innate immune responses and cognitive function, focusing specifically on how neutrophil activity influences brain health following injury. Her academic background includes: PhD from Miami University Dr. Coulibaly's research centers on neuroimmune interactions, examining how innate immune cells—particularly neutrophils—modulate cognitive processes including working memory, attention, executive function, and mental flexibility. Her laboratory employs transgenic mouse models, pharmacological interventions, behavioral testing, immunohistochemistry, and advanced imaging techniques to dissect cellular mechanisms in conditions like stroke and subarachnoid hemorrhage. Key methodologies include global and meningeal-specific neutrophil manipulation, neuronal morphology analysis, and in vitro cell culture systems to study neuron-immune cell interactions. Analysis of her recent publications reveals a cohesive research trajectory focused on neuroinflammation in acute brain injuries. Her work demonstrates how neutrophil activity contributes to long-term cognitive decline after subarachnoid hemorrhage, explores microglial roles in spinal cord injury recovery, and investigates molecular pathways in neuronal plasticity. This research program bridges immunology, neuroscience, and behavioral science to identify therapeutic targets for post-injury cognitive deficits. Scientific Awards: No awards listed in available documentation. Dr. Coulibaly leads an active research group investigating neuroimmune mechanisms, though specific grant details and student mentorship records are not publicly documented. Her work receives institutional support through West Virginia University's research infrastructure. The Coulibaly laboratory operates within the Rockefeller Neuroscience Institute, utilizing specialized facilities for behavioral testing, histology, and cellular imaging. Her team collaborates across disciplines to advance understanding of how immune responses shape cognitive outcomes following neurological injury.

Anamaria BalicView profile

Associate Professor

• Dental stem cells
• Stem cell niches
• Tooth development
• +5 more

Anamaria Balic serves as a Senior Teaching and Research Assistant at the Institute of Oral Biology, Faculty of Medicine, University of Zurich, where she conducts pioneering research in dental stem cell biology and tooth development. She holds qualifications as PD (Privatdozent), PhD, and MD, and maintains an academic appointment as Docent at the University of Helsinki, reflecting her dual institutional affiliations and recognition as an independent researcher. Dr. Balic's research program focuses on fundamental mechanisms of stem cell regulation using the continuously growing rodent incisor as a model system. Her laboratory investigates how epithelial stem cells are maintained throughout life and how mesenchymal stem cells are recruited to support ongoing tooth growth. She employs state-of-the-art genomic, cellular, and molecular biology techniques to unravel these complex processes during both embryonic development and postnatal life. Analysis of her publication record reveals a consistent trajectory of high-impact research spanning stem cell biology, tooth development, and regenerative dentistry. Her recent work (2023-2024) prominently features single-cell RNA sequencing approaches to study extracellular matrix remodeling in carious teeth and the role of Nogo-A in dental stem cell differentiation and innervation. Earlier contributions include foundational work on dental cell type atlases, Hedgehog signaling in stem cell niches, and innovative organ culture techniques for studying dental stem cells. Dr. Balic's research bridges basic science and potential clinical applications, with implications for understanding tooth agenesis, developing regenerative approaches for dental tissues, and advancing fundamental knowledge of stem cell biology. Her work demonstrates particular expertise in epithelial-mesenchymal interactions, stem cell niche organization, and molecular signaling pathways governing dental tissue development and homeostasis.

• Immunology
• Platelet Immunology
• Pregnancy Immunology
• +5 more

Gøril Heide serves as an Associate Professor within the Department of Clinical Medicine at UiT The Arctic University of Norway, Tromsø. Her academic profile centers on immunological research with direct clinical applications in pregnancy-related disorders and blood immunology. Dr. Heide's research program demonstrates deep expertise in human platelet antigen systems, particularly HPA-1a, and their role in maternal-fetal immune interactions. Her work investigates how maternal alloimmunization against fetal platelet antigens leads to complications such as Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). She has made significant contributions to understanding the genetic factors influencing HPA-1a alloimmunization risk, the functional impact of anti-HPA-1a antibodies on placental development, and the characterization of immune responses in pregnancy. Her research bridges fundamental immunology with clinical obstetrics and hematology to address critical challenges in maternal-fetal medicine. Analysis of Dr. Heide's publication record reveals a decade-long research trajectory focused on platelet immunology and pregnancy complications. Her work combines clinical observational studies with laboratory-based investigations, demonstrating expertise in immunogenetics, cellular immunology, and clinical obstetrics. Key research themes include genetic predisposition to HPA-1a alloimmunization, functional consequences of maternal antibodies on trophoblast function, and characterization of immune responses in pregnant women. Her collaborative approach involves working with multidisciplinary teams of immunologists, hematologists, and obstetricians to advance understanding of maternal-fetal immune tolerance mechanisms. Dr. Heide maintains active research collaborations within UiT and with national and international partners, contributing to the development of improved diagnostic approaches and potential therapeutic interventions for pregnancy-related immunological disorders. Her work has significant implications for preventing and managing complications arising from maternal immune responses to fetal antigens.

• Neuroscience
• Molecular Biology
• Cell Biology
• +4 more

Italia Di Liegro serves as a Contract Teacher in the Department of Biomedicine, Neuroscience and Advanced Diagnostics at the School of Medicine and Surgery, University of Palermo. She maintains regular office hours at multiple locations including Palermo's Viale delle Scienze campus (Building 16/STEBICEF) and CEFPAS in Caltanissetta, demonstrating her commitment to student accessibility across different sites. Dr. Di Liegro's research spans several decades with a consistent focus on cellular and molecular neuroscience. Her early work centered on thyroid hormones and chromatin structure in brain development, while her more recent research has evolved to investigate extracellular vesicles as critical mediators of cell-to-cell communication in the nervous system. She has made significant contributions to understanding how astrocytes contribute to blood-brain barrier function and how extracellular vesicles facilitate information exchange between brain cells in both physiological and pathological conditions. Analysis of her publication history reveals a clear research trajectory moving from fundamental molecular mechanisms to translational applications. Her recent work (2020-2024) prominently features studies on extracellular vesicles in brain tumor progression, epigenetic regulation of neural function, and development of therapeutic approaches for neurological disorders. She has developed innovative in vitro models using poly-L-lactic acid scaffolds to study astrocyte behavior and glioma development, bridging basic science with potential clinical applications. Dr. Di Liegro has supervised numerous graduate theses and mentored students in neuroscience research, though specific student names are not listed in the available materials. Her multidisciplinary approach connects molecular mechanisms with clinical applications, particularly in developing training programs for Parkinson's disease and multiple sclerosis patients. Her laboratory work primarily focuses on in vitro models of brain cells, with extensive characterization of astrocyte behavior, blood-brain barrier models, and glioma cell lines. She has pioneered methods for studying cell migration and differentiation using specialized 3D culture systems, contributing significantly to our understanding of brain development, neurological disorders, and cancer progression.

Matthew BakerView profile

Associate Professor

• Biophysics
• Bacteriology
• Biological Physics
• +8 more

Dr Matthew Baker is a Scientia Associate Professor in the School of Biotechnology and Biomolecular Sciences at the University of New South Wales (UNSW). His research focuses on biophysics, bacterial motility, evolution, and synthetic biology, with particular emphasis on understanding the bacterial flagellar motor and force-sensitive proteins. His work bridges physics, biology, and nanotechnology to explore fundamental mechanisms of cellular machinery and their evolutionary trajectories. Research Themes: Bacterial flagellar motor mechanics, ion selectivity evolution, DNA-lipid interactions, and mechanosensitive protein function across scales of life. Collaborations: Works with Dr Shelley Wickham to probe membrane dynamics using DNA nanotechnology for controlling membrane communication. Awards: 2023 Promotion to Associate Professor; 2021-24 International Union of Pure and Applied Biophysics Councillor; 2018 Scientia Research Fellowship; 2016 Google News Lab Fellowship. Teaching: Co-convener of BABS3200 synthetic biology course at UNSW. Regular science presenter on ABC Nightlife and Radio New Zealand Saturday Morning. Grant Funding: Currently funded by Human Frontier Science Program (RGY0072), Australian Research Council (DP190100497, DP210101892), CSIRO Synthetic Biology Platform Project Grant (2018-2021), and Medical Advances Without Animals (2020-2021). His lab group includes 5 PhD students, 4 postdocs, and 2 Hons students working on flagellar dynamics and in vitro lipid/DNA projects.

• Antibiotic Research
• Bacterial Cell Division
• Antimicrobial Resistance
• +3 more

Peter Sass is a Researcher leading the Microbial Bioactive Compounds group at the Interfaculty Institute of Microbiology and Infection Medicine (IMIT) within the Faculty of Mathematics and Natural Sciences at the University of Tübingen. His research focuses on bacterial cell division as a novel target for antibiotic development, with particular emphasis on the molecular mechanisms of cell division inhibitors. Dr. Sass earned his diploma in 2005 and PhD in microbiology in 2009 from the University of Bonn, where he worked in the lab of Gabriele Bierbaum. He gained additional expertise through research stays at the National University of Ireland in Maynooth and Newcastle University. He completed postdoctoral training with Hans-Georg Sahl in Bonn and Heike Brötz-Oesterhelt in Düsseldorf before establishing his research group at Tübingen in 2014. His research program investigates bacterial cell division mechanisms and explores novel approaches to target this process with antimicrobial compounds. Using advanced life-cell fluorescence microscopy and in vitro protein activity assays, his team studies how antibiotics like ADEP disrupt bacterial cell division, with particular focus on the Clp protease system and divisome dynamics. His work spans fundamental bacterial physiology and translational antibiotic discovery. Dr. Sass's publication record demonstrates consistent contributions to understanding bacterial cell division as an antibiotic target. His recent work has focused on ADEP antibiotics, cell wall stress responses, and novel approaches to combat antimicrobial resistance through targeting essential cellular processes not addressed by current therapeutics. DFG TRR 261: Cellular Mechanisms of Antibiotic Action and Production German Center for Infection Research (DZIF), TTU Novel Antibiotics DFG SFB 766: The Bacterial Cell Envelope ERASMUS Fellowship by the European Union Junior scientist award from Dr. Günther and Imme Wille foundation Member of VAAM and ASM Dr. Sass leads a research team comprising postdocs, PhD students, and MSc students, and collaborates extensively with other research groups both within Tübingen and internationally. His lab utilizes advanced microscopy platforms including Nikon Eclipse Ti and Zeiss Axio Observer Z1 systems for high-resolution bacterial cell imaging. His group has made significant contributions to understanding how antibiotics like ADEP target the Clp protease system to disrupt bacterial cell division through degradation of essential proteins like FtsZ.

Anaïs NoblancView profile

Researcher

• Molecular Biology
• Cell Biology
• Reproductive Biology
• +3 more

Anaïs Noblanc is a Researcher at the University of Poitiers, affiliated with the PRODICET Laboratory within the Biology and Health Center. Her work focuses on molecular and cell biology, particularly investigating oxidative stress mechanisms in male reproductive systems. She specializes in sperm chromatin integrity, antioxidant systems, and the physiological processes governing fertility. Her research interests include understanding how aging and oxidative damage affect sperm nuclear structure, as well as identifying protective roles of tissues like the epididymis and meibomian glands. She utilizes mouse models and in vitro systems to explore these mechanisms, contributing to advancements in male infertility treatments and antioxidant formulations. Key research trends in her publications emphasize the interplay between oxidative stress, DNA damage, and reproductive outcomes. Her work highlights compensatory mechanisms in post-testicular environments and the critical role of enzymes such as glutathione peroxidases. Collaborations with clinical partners are implied through her affiliations with university hospitals. Her current projects are centered on translational research linking basic biology to clinical applications, particularly in developing antioxidant therapies for male infertility. No specific grants or awards are listed, though her active publication record suggests sustained research engagement.

• Alzheimer's Disease
• Dementia
• Geriatric Psychiatry
• +3 more

Dr. David J. Loreck is a Clinical Assistant Professor at the University of Maryland School of Medicine's Department of Psychiatry. He leads the Baltimore VAMC Mental Health Consultation Service and Neuropsychiatry Clinic, specializing in Alzheimer's Disease, Dementia, and Geriatric Psychiatry. He holds board certifications in Adult Psychiatry, Geriatric Psychiatry, and Neuropsychiatry. Education: BA in Political Science and English Literature from University of Maryland College Park (1979), M.D. from University of Texas Medical School (1987 with honors/AOA), and completed residency/fellowship training at University of Maryland Medical System and Johns Hopkins School of Medicine (Alzheimer's Disease Research Center). Research focuses on dementia/delirium treatment in the elderly, with participation in VA clinical trials. Major contributions include developing the Baltimore VAMC Alzheimer's Disease/Memory Disorders Clinic and serving on VA Dementia Clinical Care and Delirium Field Advisory committees. He also chairs regional dementia care initiatives and advises Maryland Alzheimer's Disease boards. Awards: Graduated with Honors and Alpha Omega Alpha membership from UT Medical School. Key professional roles include service on national VA committees, Maryland Alzheimer's Scientific Board, and VA clinical care oversight. Advocacy and grants: His work integrates clinical practice with policy improvements for elderly patients with neurocognitive disorders. He has authored/co-authored over 14 peer-reviewed articles on dementia assessment, neuropsychiatric symptoms, and elder care innovation.

Rocco D'AntuonoView profile

Researcher

• Imaging
• Cell Biology
• Biomedical Engineering
• +3 more

Rocco D'Antuono is a Researcher at The Francis Crick Institute, specializing in advanced microscopy techniques and bioimage analysis. He holds a Physics background and has extensive experience in live cell imaging, confocal microscopy, and facility management. His career includes roles at the FIRC Institute for Molecular Oncology (IFOM) and the Institute for Research in Biomedicine (Bellinzona), where he contributed to microscopy and mass spectrometry facilities. His research interests revolve around imaging technologies, cell biology, and their applications in understanding disease mechanisms. He has developed open-source software tools like GIANI and ZELDA for 3D microscopy analysis, emphasizing reproducibility and collaboration in scientific imaging. He frequently collaborates with labs studying autophagy, infectious diseases, and immunology. His work spans diverse areas including tuberculosis pathology modeling, drug delivery systems for neurodegenerative diseases, and the role of endothelial cells in viral infections. He actively promotes bioimage analyst contributions to scientific research and publishing through initiatives like the NEUBIAS training schools.

• Biomedical Engineering
• Tissue Engineering
• Bioartificial Organs
• +7 more

Professor Sotiris Korossis is a leading academic in biomedical engineering and bioartificial organs. His research focuses on decellularization techniques for tissue scaffolds, cardiovascular prosthetics, biohybrid organ development, and advanced medical device design. He has pioneered studies on anticalcification strategies for bioprosthetic materials and engineered solutions for small-caliber vascular reconstructions. His work integrates computational modeling with experimental validation, addressing challenges in regenerative medicine and clinical translation. Research Interests : Decellularized tissue matrices for cardiovascular and bladder applications Material engineering for bioartificial organs (e.g., lungs, hearts) Optimization of anticoagulant and antimicrobial surface coatings Patient-specific computational modeling of heart valves and vascular systems Biomechanical analysis of tissue-engineered constructs Key Themes in Publications : Recent work emphasizes ultrasonic energy transfer for implants, genetic modifications to reduce xenotransplant immunogenicity, and computational fluid dynamics for biohybrid lung optimization. His research bridges material science, cell biology, and clinical engineering to advance regenerative therapies. Grants and collaborations drive his lab's focus on translational research, though specific projects are not detailed here. His work contributes to the development of off-the-shelf decellularized scaffolds and next-generation biohybrid organs.

Maxime CulotView profile

Professor

• Pharmacology
• Toxicology
• Cell Biology
• +3 more

Maxime Culot is a Professor at the Faculty of Sciences, University of Artois in Lens, France. He earned his Ph.D. at the same institution in 2007 and has since specialized in pharmaceutical and toxicological applications of cell and tissue culture. His research focuses on studying xenobiotics transport across biological barriers using human stem cell-derived in vitro models, particularly the blood-brain barrier (BBB). He has contributed to developing innovative BBB models for drug screening and collaborated with pharmaceutical companies and organizations like AstraZeneca. Dr. Culot coordinates the Master Tox & Ecotox program (MENACE), emphasizing New Approach Methodologies (NAMs) for toxicity assessment. He has led or participated in EU-funded projects, including FP7 Predict iv, H2020-ITN BtRAIN, and others, advancing in vitro toxicology and BBB modeling. His work integrates proteomics, cellular models, and computational tools to address neurovascular protection, drug permeability, and adverse outcome pathways. Culot’s lab develops strategies for predicting human neurotoxicity, improving drug delivery systems, and enhancing in vitro-to-in vivo extrapolation methods. His research spans interdisciplinary topics such as stem cell-derived BBB models, extracellular vesicle standardization (MISEV guidelines), and the impact of differentiation protocols on transcriptomic signatures. He also investigates challenges in oral biologic delivery and the application of NAMs to reduce animal testing reliance. Culot’s contributions bridge basic science and translational research, with a focus on advancing safer and more effective pharmaceutical and toxicological practices.

• Alzheimer's Disease
• Neurosciences
• Inflammation
• +3 more

Dr. Karen Cullen is a Senior Lecturer in the Department of Anatomy & Histology, within the School of Medical Sciences at The University of Sydney. Her research focuses on neurodegenerative diseases, particularly Alzheimer’s disease, inflammation, and cardiovascular-related neurological conditions. She investigates microvascular pathology, protein aggregation, and neurotoxic mechanisms in aging and disease. Dr. Cullen has contributed to over 20 peer-reviewed publications since 2005, exploring topics such as neuritic plaques, kynurenine pathways, and photobiomodulation effects in non-human primates. Her work spans experimental models (e.g., triple transgenic mice) and human brain tissue analysis. Key themes include understanding the interplay between microvascular dysfunction, neuroinflammation, and neurodegenerative processes. Dr. Cullen has secured grants from organizations like the Rebecca L Cooper Medical Research Foundation and the Judith Jane Mason Foundation, supporting studies on Alzheimer’s pathology and neuronal energy crises. Recent publications highlight advancements in Alzheimer’s plaque characterization, tau pathology, and actin-microtubule dynamics. Her research bridges basic science and clinical implications, aiming to uncover therapeutic targets for neurodegenerative diseases.

• Bionanoscience
• Regenerative Medicine
• Biosensing Technologies
• +4 more

Professor Dame Molly Stevens holds the John Black Professorship of Bionanoscience at the University of Oxford's Department of Physiology, Anatomy & Genetics and Institute of Biomedical Engineering, while serving as Deputy Director of the Kavli Institute for Nanoscience Discovery. She maintains part-time roles at Imperial College London and the Karolinska Institutet, Sweden. Her research focuses on biosensing, regenerative medicine, and biomaterials, with over 400 publications and an H-index exceeding 100. Stevens is a serial entrepreneur, co-founding four biotech companies and holding numerous patents. Education: PhD in Materials Science (University of Nottingham), postdoctoral training at MIT. Research interests include advanced diagnostics, bio-material interfaces, bioelectronics, and digital medicine leveraging AI. She leads the UK Regenerative Medicine Hub and the EPSRC i-sense collaboration. Awards include the Novo Nordisk Award (2023), MRS Mid-Career Researcher Award (2022), and American Chemical Society Colloid Chemistry Award (2020). A Fellow of the Royal Society, Royal Academy of Engineering, and multiple international academies, she champions interdisciplinary innovation and healthcare democratization. Advising and funding: Supervises a multidisciplinary team of over 40 researchers, with grants from ERC, UKRI, Wellcome Trust, and industry partners. Her Stevens Group develops biomaterials for soft robotics, tissue engineering, and wearable diagnostics.

J. (Jos) MaldaView profile

Professor

• Biofabrication
• Biomaterials
• Regenerative Medicine
• +5 more

Prof. J. (Jos) Malda is a Professor of Translational Regenerative Medicine at Utrecht University, holding dual roles in the Faculty of Veterinary Medicine (Department of Equine Sciences) and the University Medical Center Utrecht’s Department of Orthopedics. His research focuses on biofabrication and biomaterials for regenerative medicine, particularly in cartilage and bone repair. He leads the Biofabrication in Translational Regenerative Medicine group, emphasizing 3D printing, bioreactors, and bioinks. Key areas include osteochondral defect regeneration, with applications in both veterinary and human medicine. Education includes a PhD in Tissue Engineering from the University of Twente (2004) and a Master’s in Bioprocess Engineering from Wageningen University (1999). He has held academic positions since 2010, including roles at Queensland University of Technology. Notable achievements include the Veni Laureate Research Fellowship (2007–2010). Research highlights innovative biofabrication strategies, such as melt electrowriting and volumetric bioprinting, to create functional tissues. Collaborations span labs like the Utrecht Biofabrication Facility and international institutions. His work bridges fundamental science with clinical translation, advancing therapies for joint diseases and tissue defects. Awards include the Veni Laureate, and he contributes to academic leadership as Head of Research in Orthopedics. His lab’s projects aim to engineer patient-specific tissues using advanced biomaterials and bioprinting, with potential in personalized regenerative solutions.